Home Home Home Inbox Home Search

Event

P1501 Clinical Response to Crizotinib as a 1st and 2nd Line Therapy in ALK Positive Lung Cancer in an Indian Population

Monday
May
22
9:15 AM
4:15 PM
Type : Scientific Abstract
Home Home Home Inbox Home Search